Baillie Gifford - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 322 filers reported holding 10X GENOMICS INC in Q1 2021. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$344,062,043
-27.5%
8,340,898
-1.9%
0.31%
-22.3%
Q2 2023$474,877,153
-2.8%
8,504,247
-2.9%
0.40%
-8.4%
Q1 2023$488,384,935
+55.8%
8,753,987
+1.8%
0.44%
+34.9%
Q4 2022$313,465,444
+30.4%
8,602,235
+1.9%
0.33%
+31.9%
Q3 2022$240,467,000
-36.6%
8,443,388
+0.8%
0.25%
-36.2%
Q2 2022$379,148,000
-32.2%
8,378,971
+13.9%
0.39%
-0.8%
Q1 2022$559,552,000
-45.4%
7,355,764
+6.9%
0.39%
-30.2%
Q4 2021$1,024,603,000
+27.0%
6,878,377
+24.1%
0.56%
+33.2%
Q3 2021$806,896,000
-18.1%
5,542,625
+10.2%
0.42%
-12.1%
Q2 2021$985,169,000
+289.9%
5,030,996
+260.4%
0.48%
+240.4%
Q1 2021$252,698,000
+130.3%
1,396,126
+80.1%
0.14%
+131.1%
Q4 2020$109,743,000
+72.1%
775,020
+51.5%
0.06%
+38.6%
Q3 2020$63,767,000
+16506.0%
511,447
+11802.4%
0.04%
Q2 2020$384,000
+287.9%
4,297
+170.4%
0.00%
Q1 2020$99,0001,5890.00%
Other shareholders
10X GENOMICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 708,528$29,226,780100.00%
Meritech Capital Associates V L.L.C. 494,236$20,387,2356.48%
Sands Capital Ventures, LLC 481,770$19,873,0135.88%
Decheng Capital Management III (Cayman), LLC 359,554$14,831,6034.95%
Iron Triangle Partners LP 666,945$27,511,4814.02%
Endurant Capital Management LP 71,044$2,930,5652.63%
Brown Capital Management 3,081,105$127,095,5811.95%
RTW INVESTMENTS, LP 1,519,956$62,698,1851.32%
Parametrica Management Ltd 15,300$631,1251.06%
Capital Impact Advisors, LLC 14,821$611,3661.02%
View complete list of 10X GENOMICS INC shareholders